Skip To Main Content
Rosa Tambaro on Muck Rack

Rosa Tambaro

As seen in: Future Medicine, European Urology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rosa

Contact Rosa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial

|
By Francesca Vignani, Rosa Tambaro, Ugo De Giorgi, Patrizia Giannatempo
| European Urology Verified
Background Platinum-based chemotherapy (PBCT) is the standard first-line treatment for advanced urothelial carcinoma (UC). Potential cross-sensitivity can be hypothesized between platinum drugs and poly-ADP ribose-polymerase (PARP) inhibitors. Objective To compare maintenance treatment with the PARP inhibitor niraparib plus best supportive care (BSC) versus BSC alone in patients with advanced UC without disease progression after first-line PBCT.
Open in Who Shared Issue with article?

From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer

|
By Carmela Pisano, Sabrina Chiara Cecere, Rosa Tambaro, Marilena Di Napoli
| Future Medicine Verified
Metrics Downloaded 0 times History Received 6 May 2020 Accepted 23 September 2020 Published online 12 October 2020 Information © 2020 Future Medicine Ltd KeywordsAcknowledgments Editorial assistance was performed by L Brogelli, B Bartolini and A Shah of Polistudium srl (Milan, Italy); this assistance was supported by internal funds.
Open in Who Shared Issue with article?
See all 2 articles